Archive Newsletter

  1. 08.08.26 -- Cell & Gene Newsletter - Best Of July 8/8/2026
    08/08/26 Cell & Gene Newsletter
  2. 08.07.26 -- New Podcast Episodes: BoB@BIO, In Vivo Gene Editing, Multispecific Manufacturability, and More 8/7/2026
    08/07/26 Cell & Gene Newsletter
  3. 08.07.26 -- Inside ImvivaBio's Trial For Off-The-Shelf CAR-T Strategy For Aggressive T-Cell Malignancies 8/7/2026
    08/07/26 Cell & Gene Newsletter
  4. 08.06.26 -- The CDMO Perspective On Breaking Down Development Silos In Vivo CGT 8/6/2026
    08/06/26
  5. 08.05.26 -- Advancing Precision In Clinical Trial Design 8/5/2026
    08/05/26 Cell & Gene Newsletter
  6. 08.05.26 -- How Precision Oncology Is Redefining Cancer Drug Development With Aprea Therapeutics' Dr. Oren Gilad 8/5/2026
    08/05/26 Cell & Gene Newsletter
  7. 08.04.26 -- De-Risk MSC Development From Source To Scale 8/4/2026

    08/04/26 Cell & Gene Newsletter

  8. 08.04.26 -- STREAM Edition: When Great Biology Meets Manufacturing Reality 8/4/2026

    08/04/26 Cell & Gene Newsletter

  9. 08.03.26 -- CGT Modality, Hybrid Models, And What To Keep In-House 8/3/2026
    08/03/26 Cell & Gene Newsletter
  10. 07.31.26 -- Supply Chain Orchestration, Priorities For Smaller CGT Biotechs 7/31/2026
    07/31/26 Cell & Gene Newsletter